ribavirin has been researched along with Rubulavirus Infections in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cumaraswamy, S; Hou, Y; Kalimuddin, S; Lai, SH; Low, CY; Ooi, EE; Sessions, OM; Sim, D; Tan, TE | 1 |
Hohenthal, U; Itälä, M; Kotilainen, P; Nikoskelainen, J; Peltonen, R; Routamaa, M; Vainionpää, R | 1 |
2 other study(ies) available for ribavirin and Rubulavirus Infections
Article | Year |
---|---|
Successful clearance of human parainfluenza virus type 2 viraemia with intravenous ribavirin and immunoglobulin in a patient with acute myocarditis.
Topics: Administration, Intravenous; Antiviral Agents; Humans; Immunoglobulins, Intravenous; Male; Middle Aged; Molecular Sequence Data; Myocarditis; Parainfluenza Virus 2, Human; Ribavirin; RNA, Viral; Rubulavirus Infections; Sequence Analysis, DNA; Treatment Outcome | 2013 |
Human parainfluenza type 4 virus (hPIV4) infection provoking many questions regarding the role of this virus as the causative agent of respiratory tract infections in the post-transplant setting.
Topics: Antiviral Agents; Bone Marrow Transplantation; Child; Cross Infection; Diagnosis, Differential; Humans; Immunocompromised Host; Parainfluenza Virus 3, Human; Parainfluenza Virus 4, Human; Respiratory Tract Infections; Respirovirus Infections; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; Rubulavirus Infections; Virulence | 2002 |